Axim Biotechnologies Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
0.10
661.10
134.20
713.30
2,057.80
1,955.60
Total Accounts Receivable
3.00
5.00
5.00
505.00
5.00
5
Inventories
-
-
200.80
38.40
8.80
9.80
Other Current Assets
-
72.30
842.80
116.90
41.00
52.10
Total Current Assets
3.10
738.50
1,182.80
1,373.70
2,112.60
2,022.50
Net Property, Plant & Equipment
-
-
15.70
12.30
8.90
5.60
Total Investments and Advances
-
-
-
-
7.40
-
Intangible Assets
53.70
-
63.20
63.20
63.20
53.70
Total Assets
56.80
738.50
1,261.60
1,449.20
2,192.20
2,089.30
ST Debt & Current Portion LT Debt
50.00
1,109.00
1,073.00
903.00
5,448.20
Accounts Payable
53.00
116.30
324.00
401.20
441.80
Other Current Liabilities
47.80
93.80
1,148.60
1,712.60
1,815.10
Total Current Liabilities
150.70
1,319.20
2,545.60
3,016.80
7,705.10
Long-Term Debt
-
-
400.00
787.50
687.50
Other Liabilities
-
-
11.20
16.40
84.00
Total Liabilities
150.70
1,319.20
2,956.80
3,820.80
8,476.60
Common Equity (Total)
94.00
580.80
1,695.40
2,371.70
6,284.60
Total Shareholders' Equity
93.90
580.70
1,695.20
2,371.60
6,284.50
Total Equity
93.90
580.70
1,695.20
2,371.60
6,284.50
Liabilities & Shareholders' Equity
56.80
738.50
1,261.60
1,449.20
2,192.20
Preferred Stock (Carrying Value)
0.10
0.10
0.20
0.10
0.10
About Axim Biotechnologies
View Profile
